Oscar Health CEO granted 1.6M RSUs

Bertolini Mark T reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Bertolini Mark T reported acquisition or exercise transactions in this Form 4 filing.

Oscar Health, Inc. reported that Chief Executive Officer Mark T. Bertolini received an award of 1,596,877 shares of Class A common stock in the form of restricted stock units at a price of $0.00 per share. These units will vest in three equal annual installments beginning on March 2, 2027, as long as he continues serving as CEO or as a board member through each vesting date. After this grant, he beneficially owns 4,463,543 shares of Class A common stock, which includes shares that may be issued upon future vesting of restricted stock units.

Insider Trade Summary

Grant/Award: 1,596,877 shares

Grant/Award 1 txn

Insider Bertolini Mark T

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	1,596,877	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 4,463,543 shares (Direct)

Footnotes (2)

1. F1. The shares represent restricted stock units, which will vest in three equal annual installments beginning on March 2, 2027, subject to the Reporting Person's continued employment or service as the Chief Executive Officer or as a member of the Board of Directors through the applicable vesting date.
2. F2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Oscar Health (OSCR) disclose about Mark Bertolini’s latest equity award?

Oscar Health disclosed that CEO Mark T. Bertolini received 1,596,877 restricted stock units of Class A common stock at $0.00 per share. The award is structured as a long-term incentive and will vest over multiple years if he continues in leadership roles.

How do Mark Bertolini’s new restricted stock units vest at Oscar Health (OSCR)?

The 1,596,877 restricted stock units granted to Mark Bertolini vest in three equal annual installments starting March 2, 2027. Vesting requires his continued employment as Chief Executive Officer or service on the Board of Directors through each scheduled vesting date.

What is Mark Bertolini’s total reported ownership in Oscar Health (OSCR) after this Form 4?

After this grant, Mark Bertolini is reported to beneficially own 4,463,543 shares of Oscar Health Class A common stock. This figure includes shares that may be issued in the future upon the vesting of one or more outstanding restricted stock unit awards.

Was there any cash paid for Mark Bertolini’s new Oscar Health (OSCR) shares?

No cash changed hands for this transaction; the 1,596,877 shares were granted at $0.00 per share as restricted stock units. This reflects an equity-based compensation award rather than an open-market purchase of Oscar Health Class A common stock.

What roles must Mark Bertolini hold for his Oscar Health (OSCR) RSUs to vest?

For the restricted stock units to vest, Mark Bertolini must remain either Chief Executive Officer or a member of the Board of Directors. Continued service in one of these roles through each vesting date is required for the annual installments to be delivered.

Does the Oscar Health (OSCR) filing mention other restricted stock units for Mark Bertolini?

Yes, the filing notes that his reported beneficial ownership includes shares to be issued upon the vesting of one or more restricted stock units. This means some of the 4,463,543 reported shares reflect future issuances tied to outstanding equity awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 04:22 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bertolini Mark T

(Last) (First) (Middle)

75 VARICK STREET, 5TH FLOOR

(Street)

NEW YORK NY 10013

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Oscar Health, Inc. [ OSCR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/02/2026		A		1,596,877(1)	A	$0	4,463,543(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares represent restricted stock units, which will vest in three equal annual installments beginning on March 2, 2027, subject to the Reporting Person's continued employment or service as the Chief Executive Officer or as a member of the Board of Directors through the applicable vesting date.

2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.

Remarks:

	/s/ Melissa Curtin, Attorney-in-Fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.